- £1.18bn
- £1.42bn
- £689.70m
- 52
- 21
- 33
- 25
2019 June 30th | R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 489 | 551 | 574 | 593 | 690 |
Cost of Revenue | |||||
Gross Profit | 179 | — | — | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 480 | 509 | 527 | 544 | 649 |
Operating Profit | 8.7 | 42.4 | 47.7 | 49.4 | 40.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.9 | 46.3 | 55.8 | 48.4 | 39.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.7 | 35.7 | 46.8 | 36.7 | 31.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7.8 | 35.3 | 47.3 | 40.9 | 33.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.8 | 35.3 | 47.3 | 40.9 | 33.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.509 | 0.637 | 0.9 | 0.711 | 0.754 |
Dividends per Share |